Diabetes, microvascular complications, and cardiovascular complications: what is it about glucose?
- 1Section of Endocrinology (111H), Veterans Affairs Medical Center, 1055 Clermont Street, Denver, Colorado 80220, USA. jane.reusch@uchsc.edu
- 0Section of Endocrinology (111H), Veterans Affairs Medical Center, 1055 Clermont Street, Denver, Colorado 80220, USA. jane.reusch@uchsc.edu
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Poor glycemic control drives diabetic complications. A new study links oxidant activation of poly(ADP-ribose) polymerase (PARP) to these injuries, suggesting PARP inhibitors could prevent diabetic complications.
Area Of Science
- Biochemistry
- Molecular Biology
- Endocrinology
Background
- Glycemic control is central to managing diabetic complications, affecting both microvascular and macrovascular health.
- Oxidative stress is implicated in the pathogenesis of diabetic complications.
Discussion
- This study uncovers a novel link between oxidant-induced activation of poly(ADP-ribose) polymerase (PARP) and the enhancement of pathways mediating glycemic injury.
- The findings suggest that PARP activation is a key player in the molecular mechanisms underlying diabetic complications.
Key Insights
- A previously unrecognized association between oxidant activation of PARP and the upregulation of mediators of glycemic injury has been identified.
- This highlights a significant molecular pathway contributing to the development of diabetic complications.
Outlook
- Poly(ADP-ribose) polymerase (PARP) inhibitors show promise as a potential therapeutic strategy.
- Targeting PARP may offer a novel approach to prevent or mitigate diabetic microvascular and macrovascular complications.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.